After Failed Trials, Johnson & Johnso...

After Failed Trials, Johnson & Johnson Turns to Early Stage Alzheimer's

There are 3 comments on the BioSpace story from Feb 13, 2013, titled After Failed Trials, Johnson & Johnson Turns to Early Stage Alzheimer's. In it, BioSpace reports that:

A little over a year ago, Dr. Husseini Manji, global head of neuroscience drug development at Johnson & Johnson, predicted that brain researchers were on the cusp of a golden age.

Join the discussion below, or Read more at BioSpace.

Mikehawkslarge

El Cajon, CA

#1 Feb 13, 2013
These drugs to remove or prevent plaques will always fail. Not only that, but the bapineuzumab and other antibody meds will increase the cause (Inflamation of the brain) and make things worse. The plaque is not the cause, the inflamation is. Chronic Inflamation results in brain cells responding by making plaques in an attempt to wall off injury and this results in worsening disease. So to be successful you must stop the inflamation OR identify and remove all excitotoxins from our food supply. Substances which are chronically ingested within our food supply are ramping up excitotoxicity. A vaccine is likely to result in an inflamatory response and accelerate the onset.
The phamaceutical industry must learn to treat the actual problem rather than attemting to reduce symptoms. Unfortunately eliminating the problem does not make them the kind of money they get by making people addicts to medications. That is the biggest problem in healthcare, and money will always trump health and wellbeing.
Mikehawkslarge

El Cajon, CA

#2 Feb 13, 2013
Sorry, in my haste, my previous post had a few typos...I really hate that so here it is corrected:
These drugs to remove or prevent plaques will always fail. Not only that, but the bapineuzumab and other antibody meds will increase the cause (Inflammation of the brain) and make things worse. The plaque is not the cause, the inflammation is. Chronic Inflammation results in brain cells responding by making plaques in an attempt to wall off injury and this results in worsening disease. So to be successful you must stop the inflammation OR identify and remove all excitotoxins from our food supply. Substances which are chronically ingested within our food supply are ramping up excitotoxicity. A vaccine is likely to result in an inflammatory response and accelerate the onset.
The pharmaceutical industry must learn to treat the actual problem rather than attempting to reduce symptoms. Unfortunately eliminating the problem does not make them the kind of money they get by making people addicts to medications. That is the biggest problem in healthcare, and money will always trump health and wellbeing.
Elyza

Kansas City, MO

#3 Feb 22, 2013
Mikehawkslarge wrote:
Sorry, in my haste, my previous post had a few typos...I really hate that so here it is corrected:
These drugs to remove or prevent plaques will always fail. Not only that, but the bapineuzumab and other antibody meds will increase the cause (Inflammation of the brain) and make things worse. The plaque is not the cause, the inflammation is. Chronic Inflammation results in brain cells responding by making plaques in an attempt to wall off injury and this results in worsening disease. So to be successful you must stop the inflammation OR identify and remove all excitotoxins from our food supply. Substances which are chronically ingested within our food supply are ramping up excitotoxicity. A vaccine is likely to result in an inflammatory response and accelerate the onset.
The pharmaceutical industry must learn to treat the actual problem rather than attempting to reduce symptoms. Unfortunately eliminating the problem does not make them the kind of money they get by making people addicts to medications. That is the biggest problem in healthcare, and money will always trump health and wellbeing.
@ Mikehawkslarge, I have to agree with you. It makes you wonder if drug companies ever cared about what is best for consumers/patients or what is best for their numbers. As I was scouring the net, I also came across this article at http://news.yahoo.com/depuy-asr-lawsuit-hip-i... that is related to one of the mishaps by Johnson and Johnson.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News SoCal company recalls Liquimax vitamins (Jul '08) Oct 12 Sindi 34
News Second Opinion | Blacked-out information reveal... Sep 30 Pill 1
News FHA Mortgage Focus Fuels Lend America's Rise (Jan '09) Sep 22 BRIAN FRIED Inven... 835
News FDA advisors give a thumbs-up to GlaxoSmithKlin... Sep '17 CONFLICT of INTEREST 1
News Transgender teenager Jazz Jennings signed to be... (Mar '15) Aug '17 TipsyFromCentralC... 4
News PharMerica expects growth after KKR buys it for... Aug '17 Common_sense 1
News Appalachian congressmen ask FDA to reclassify O... (May '07) Aug '17 Viking Power 38
More from around the web